Stocks and Investing Stocks and Investing
Tue, November 24, 2020
Mon, November 23, 2020

Raghuram Selvaraju Maintained (SPRO) at Strong Buy with Increased Target to $33 on, Nov 23rd, 2020


Published on 2024-10-27 14:50:53 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Spero Therapeutics, Inc." (SPRO) at Strong Buy with Increased Target from $28 to $33 on, Nov 23rd, 2020.

Raghuram has made no other calls on SPRO in the last 4 months.



There is 1 other peer that has a rating on SPRO. Out of the 1 peers that are also analyzing SPRO, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Josh Schimmer of "Evercore ISI Group" Initiated at Buy and Held Target at $70 on, Tuesday, September 29th, 2020
Contributing Sources